Mohamed A. Kandeil
Bani Suwayf, BNS 62511, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Protective effects of biogenic selenium nanoparticles synthesized by Chlorella Vulgaris against bisphenol a-induced metabolic disturbances in rats.
Journal: Discover nano
Published: January 04, 2026
Expression patterns of ANRIL and GAS-5 and genetic variants in breast cancer.
Journal: Molecular biology reports
Published: November 14, 2025
Neuroprotective effects of Chlorella vulgaris loaded niosomes via SIRT1 activation in aluminum chloride-induced Alzheimer's model.
Journal: Scientific reports
Published: July 04, 2025
Formulation and Evaluation of Astaxanthin-Loaded Invasomes as Therapeutic Approaches for Alzheimer's Disease Induced in Rats: Role of SIRT-1/BDNF/miRNA-134/GSK-3β Signaling.
Journal: Molecular neurobiology
Published: May 14, 2025
A novel cardioprotective mechanism of rosuvastatin: restoring PINK1/parkin-mediated mitophagy via SIRT1/FOXO1 activation in doxorubicin-induced cardiotoxicity.
Journal: Cancer chemotherapy and pharmacology
Published: March 19, 2025
Fumaric acid protects rats from ciprofloxacin-provoked depression through modulating TLR4, Nrf-2, and p190-rho GTP.
Journal: Drug and chemical toxicology
Published: November 20, 2024
Protective effects of Silibinin and cinnamic acid against paraquat-induced lung toxicity in rats: impact on oxidative stress, PI3K/AKT pathway, and miR-193a signaling.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 12, 2024
Exosomal miR-122, miR-128, miR-200, miR-298, and miR-342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR-4/FoxO3 pathway.
Journal: Archiv der Pharmazie
Published: October 30, 2023
Circular SERPINA3 and its target microRNA-944 as potential biomarkers in hepatitis C virus-induced hepatocellular carcinoma in Egyptian population.
Journal: Non-coding RNA research
Published: March 24, 2023
A novel protective modality against rotenone-induced Parkinson's disease: A pre-clinical study with dulaglutide.
Journal: International immunopharmacology
Published: November 25, 2022
Last Updated: 09/26/2026